Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
ALPS Medical Breakthroughs ETF Stock Price, Quotes and Forecasts
SBIOARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
85.22M
Fund Score
ALPS Medical Breakthroughs ETF Price, Quotes and Forecasts | ARCA:SBIO | Benzinga
Explore ALPS Medical Breakthroughs ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SBIO.
| Open | $28.44 |
| High | $28.44 |
| 52 Wk High | $42.73 |
| AUM | 85.22M |
| Dividend | $0.62 |
| Ex-Div Date | Dec 19, 2024 |
| Volume | 4.6K |
| Market Cap | $4.03B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 12.58 |
| Prev. Close | $28.52 |
| Low | $27.47 |
| 52 Wk Low | $27.92 |
| Shares Out | 3.20M |
| Yield | 2.18% |
| Div. Freq | Annual |
| Avg. Volume Daily | 13.21K |
| Beta | 0.90 |
| Avg. Expense Ratio | 0.5% |
| P/B Ratio | 3.27 |
Recent News
FAQ
Q
How do I buy ALPS Medical Breakthroughs ETF (SBIO) stock?
A
You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.
Q
Who are ALPS Medical Breakthroughs ETF (SBIO) competitors?
A
There are no as such competitors for ALPS Medical Breakthroughs ETF.
Q
What is the forecast, or price target, for ALPS Medical Breakthroughs ETF (SBIO) stock?
A
There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.
Q
What is the current price for ALPS Medical Breakthroughs ETF (SBIO)?
A
The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $27.47 last updated April 1, 2025 at 1:38 PM EDT.
Q
Does ALPS Medical Breakthroughs ETF (SBIO) pay a dividend?
A
There are no upcoming dividends for ALPS Medical Breakthroughs ETF.
Q
When is ALPS Medical Breakthroughs ETF (ARCA:SBIO) reporting earnings?
A
ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.
Q
Is ALPS Medical Breakthroughs ETF (SBIO) going to split?
A
There is no upcoming split for ALPS Medical Breakthroughs ETF.
| Open | $28.44 |
| High | $28.44 |
| 52 Wk High | $42.73 |
| AUM | 85.22M |
| Dividend | $0.62 |
| Ex-Div Date | Dec 19, 2024 |
| Volume | 4.6K |
| Market Cap | $4.03B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 12.58 |
| Prev. Close | $28.52 |
| Low | $27.47 |
| 52 Wk Low | $27.92 |
| Shares Out | 3.20M |
| Yield | 2.18% |
| Div. Freq | Annual |
| Avg. Volume Daily | 13.21K |
| Beta | 0.90 |
| Avg. Expense Ratio | 0.5% |
| P/B Ratio | 3.27 |
About ALPS ETF Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Dec 30, 2014 |
| Managers | Charles Perkins Andrew Hicks Ryan Mischke |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
Investment Policy
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| PCVX | Vaxcyte Inc | 5.18% |
| CERE | Cerevel Therapeutics H... | 5.04% |
| VKTX | Viking Therapeutics In... | 4.45% |
| RVMD | Revolution Medicines I... | 4.30% |
| SMMT | Summit Therapeutics Pl... | 4.14% |
| IE | Alkermes Plc | 4.58% |
| AXSM | Axsome Therapeutics, I... | 5.10% |
| CRNX | Crinetics Pharmaceutic... | 2.74% |
| CORT | Corcept Therapeutics I... | 2.13% |
| MRUS | Merus Nv | 2.10% |
| VRNA | Verona Pharma Plc | 4.70% |
| PTCT | Ptc Therapeutics Inc | 3.52% |
| ZLAB | Zai Lab Ltd | 3.12% |
| RNA | Avidity Biosciences In... | 3.02% |
| AKRO | Akero Therapeutics Inc | 2.83% |
| RYTM | Rhythm Pharmaceuticals... | 2.78% |
| ACAD | Acadia Pharmaceuticals... | 2.69% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved